CYC vs ECS

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

44LOW

ECS

ECSBOTANIC FPO [ECS]

44LOW

Score Breakdown

CYC ECS
Technical
59
51
Catalyst
55
51
Sentiment
50
50
Fundamental
55
42
Momentum
39
51
Risk Gate
50
27

Key Metrics

CYC Metric ECS
$94.2MMarket Cap$8.0M
97KAvg Volume (20d)1.2M
+0.0%Short InterestN/A
$1.47552-Week High$0.014
$0.56052-Week Low$0.004
-1.0%Daily Change+0.0%
$0.792Entry Price$0.005
-49.3%ROE-18.3%
-53.3%Profit Margin-21.9%

Active Signals

CYC Signals

●MACD momentum is picking up steam
●Volume surging at 2.0x normal while price climbs — real buying conviction behind this move
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (2.9x)
●Moderate revenue growth (+18%)
●EPS estimates revised upward (+10pts)

ECS Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume surging at 9.1x normal while price falls — heavy selling pressure
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (0.4x)

Ask Scout AI to compare CYC and ECS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYC Full Analysis → ECS Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).